Further analysis in UCSC Xena demonstrated that high expression of these genes was significantly associated with the MLL status in the TARGET ALL (phase I) database, presenting a high correlation with the status of MLL fusion (Figure 5(a)). The gene discussed is KMT2A; the disease is acute lymphoblastic leukemia.